Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESUS-AMI: Intracoronary IGF-1 in STEMI
NCT01438086Phase 2Completed
- Sponsor
- University College Cork
- Start
- Oct 2011
- Primary completion
- Feb 2016
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of mecasermin in ST elevation myocardial infarction (STEMI) (3 arms), sponsored by University College Cork. Primary endpoints: Serum glucose measurement at 30 minutes and Percent change in global left ventricular ejection fraction at 8 weeks. Started Oct 2011; status: completed.
02
Drugs
mecasermin
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01438086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01438086.